O
DNDN

OrbiMed’s DENDREON CORPORATION DNDN Stock Holding History

OrbiMed’s Portfolio DNDN Stock Details DNDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-698,900
Closed -$2.88M – 145
2013
Q2 		$2.88M Buy
+698,900
New +$2.97M 0.06% 116

Other funds holding DNDN

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AGCJ
Alden Global Capital (Jersey) St. Helier, Jersey $415M AUM 31.95% 1-Year Est. Return

OrbiMed's DNDN Position: Q4 2013 in Review

OrbiMed sold out of DENDREON CORPORATION (DNDN) in Q4 2013, closing a stake of 868,000 shares — an estimated $2.54M sold.

OrbiMed first reported a position in DNDN in Q2 2013 and held it in 2 quarters. The position peaked at $16.9M in Q2 2013. 132 funds tracked by Wall St. Rank hold DNDN as of Q4 2013.

  • OrbiMed reported no remaining DENDREON CORPORATION position as of Q4 2013 after selling out during the quarter.
  • OrbiMed sold 868,000 DENDREON CORPORATION shares in Q4 2013, an estimated $2.54M.
  • OrbiMed first reported a position in DENDREON CORPORATION in Q2 2013 and held it in 2 quarters.
  • OrbiMed's DENDREON CORPORATION position peaked at $16.9M in Q2 2013.
  • 132 funds tracked by Wall St. Rank held DENDREON CORPORATION as of Q4 2013.

Based on OrbiMed's 13F filing for Q4 2013, filed 14 Feb 2014.